World's Best Scientists 2026 revealed!
Genes and Diseases
H-index 31

Genes and Diseases

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Genetics 142 25 30 4
Biology and Biochemistry 234 107 142 25
Medicine 2664 43 42 8

Additional Metrics

Number of Best Scientists*: 271
Documents by Best Scientists*: 291
Top 100 Ranked Scientists*: 4
SCIMAGO H-index: 63
SCIMAGO SJR: 1.646
Impact Factor: 9.4

Overview

Top Research Topics at Genes and Diseases?

The journal was organized to reinforce research efforts on Cancer research, Cell biology, Internal medicine, Cancer and Bioinformatics. The Cancer research works featured in the journal incorporate elements from Cancer cell, Apoptosis, Carcinogenesis, Gene and Metastasis. Gene studies tackled cover an aspect of the field of Genetics.

While Cell biology is the focus of Genes and Diseases, it also provided insights into the studies of Transcription factor and Cell growth. Endocrinology and Oncology are some topics wherein Internal medicine research discussed in it have an impact. Breast cancer is a major topic of Cancer research presented in Genes and Diseases.

The studies tackled, which mainly focus on Bioinformatics, apply to Disease as well.

  • Cancer research (21.56%)
  • Cell biology (21.38%)
  • Internal medicine (13.01%)

What are the most cited papers published in the journal?

  • Bone Morphogenetic Protein (BMP) signaling in development and human diseases. (520 citations)
  • Temozolomide resistance in glioblastoma multiforme (331 citations)
  • Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas (294 citations)

Research areas of the most cited articles at Genes and Diseases:

The journal publications mostly deal with topics like Bioinformatics, Cancer, Cell biology, Cancer research and Stem cell. The most cited papers focus on Bioinformatics but the discussions also offer insight into other areas such as Chromatin, microRNA, Disease and Carcinogenesis. The most cited papers explore topics in Cancer which can be helpful for research in disciplines like Interferon, Clinical trial and Drug.

What topics the last edition of the journal is best known for?

  • Gene
  • Cancer
  • Internal medicine

The previous edition focused in particular on these issues:

The aim of the journal is to expand the discussion of research in Cancer research, Cell biology, Signal transduction, Cancer and Pathogenesis. The overlapping concepts between Metastasis and Tumor microenvironment are the key highlights of Cancer research study. The journal tackles studies in microRNA and the interrelated subject of Function (biology) to gain insights into Cell biology.

In it, T cell and Neuroscience are investigated in conjunction with one another to address concerns in Signal transduction research. In particular, the Cancer works presented emphasize discussions on Breast cancer. While the primary focus in the journal is Pathogenesis, it also dissects topics surrounding Inflammation and Immune system as a whole.

The most cited articles from the last journal are:

  • Notch signaling: Its essential roles in bone and craniofacial development. (11 citations)
  • Alternative polyadenylation of mRNA and its role in cancer. (10 citations)
  • Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury. (9 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Genes and Diseases (based on the number of publications) are:

  • Tong-Chuan He (34 papers) published 3 papers at the last edition, 2 less than at the previous edition,
  • Rex C. Haydon (20 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Hue H. Luu (20 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Russell R. Reid (18 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Michael J. Lee (18 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Genes and Diseases (based on the number of publications) are:

  • Chongqing Medical University (140 papers) published 35 papers at the last edition, 8 less than at the previous edition,
  • University of Chicago (58 papers) published 4 papers at the last edition, 4 less than at the previous edition,
  • Shanghai Jiao Tong University (22 papers) published 8 papers at the last edition, 4 more than at the previous edition,
  • Central South University (19 papers) published 8 papers at the last edition, 4 more than at the previous edition,
  • Fudan University (18 papers) published 5 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.11% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 46.15% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.23% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.85% of all publications and 30.77% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • CCL5/CCR5 axis in human diseases and related treatments.

    Zhen Zeng;Tianxia Lan;Yuquan Wei;Xiawei Wei

    (2021)
    192 Citations
  • Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials.

    (2022)
    137 Citations
  • NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.

    Xiaoguang Liu;Yilei Zhang;Li Zhuang;Kellen L. Olszewski

    (2021)
    95 Citations
  • Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance

    Xi Jie Liu;Jimin Xu;Jia Zhou;Qiang Shen

    (2021)
    83 Citations
  • The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases

    (2020)
    77 Citations
  • Targeting angiogenesis for liver cancer: Past, present, and future.

    Xiao-Dong Zhu;Zhao-You Tang;Hui-Chuan Sun

    (2020)
    75 Citations
  • Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19

    Jilei Zhang;Shari Garrett;Jun Sun

    (2021)
    74 Citations
  • Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications.

    Tianai Sun;Jen-Tsan A. Chi

    (2020)
    72 Citations
  • Breast and gut microbiome in health and cancer

    Jilei Zhang;Yinglin Xia;Jun Sun

    (2021)
    71 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond becoming a physician, there are several online degree options that offer promising pathways. Many students explore programs in Health Information Management, which can be conveniently pursued through a health information management degree online. These programs equip students with skills in managing patient data and healthcare systems efficiently.

Another growing field is medical coding and billing. Understanding the nuances between different certification levels, such as the cpc vs ccs certifications, is crucial for career advancement. These certifications often impact salary prospects and job responsibilities within healthcare administration.

Curious about earnings in this field? Many wonder how much do medical coders make, and the answer varies by experience and location but generally shows solid growth potential.

Finally, the job outlook for medical billing and coding remains positive, driven by increased demand for accurate healthcare records and insurance processing. These fields offer stability and opportunities for remote work, making them attractive alternatives or complements to traditional medical studies.

Best Scientists Contributing to This Journal